SCHEDULE 13G/A: BlackRock Discloses 4.4% Passive Stake in Kodiak Sciences Inc.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a 4.4% passive beneficial ownership stake in Kodiak Sciences Inc. as of March 31, 2025.

Summary

• BlackRock, Inc. filed an Amendment No. 2 to Schedule 13G regarding its beneficial ownership in Kodiak Sciences Inc.
• As of March 31, 2025, BlackRock, Inc. beneficially owns an aggregate of 2,301,991 shares of Kodiak Sciences Inc. Common Stock.
• This represents 4.4% of the class of securities.
• BlackRock holds sole voting power over 2,259,681 shares and sole dispositive power over 2,301,991 shares.
• The filing indicates that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
• Several BlackRock subsidiaries are identified as entities through which the securities are held, none of which individually own 5% or greater of the outstanding shares.

Sentiment

Score: 6

Explanation: The document is a neutral, factual disclosure of beneficial ownership. The presence of a large institutional investor like BlackRock can be seen as a positive signal of confidence, but the passive nature and lack of specific company performance data keep the sentiment from being strongly positive.

Positives

• BlackRock's passive stake suggests a long-term investment perspective rather than an activist intent.
• The holding is part of BlackRock's ordinary course of business, indicating routine portfolio management.

Negatives

• The stake is below the 5% threshold, meaning BlackRock is not a major shareholder requiring more detailed reporting (e.g., Schedule 13D), which limits insight into their specific investment thesis.
• The filing does not provide any forward-looking statements or commentary on Kodiak Sciences Inc.'s performance or strategy.

Future Outlook

This Schedule 13G filing is a disclosure of beneficial ownership and does not contain any forward-looking statements or guidance regarding Kodiak Sciences Inc.'s future performance or BlackRock's future investment intentions beyond the passive nature of the holding.

Management Comments

• "The securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11." (Certification by BlackRock, Inc.)

Industry Context

This filing reflects a routine disclosure by a major institutional investor, BlackRock, Inc., regarding its passive stake in a biotechnology company, Kodiak Sciences Inc. Such filings are common and indicate ongoing portfolio management by large asset managers. The 4.4% stake is below the 5% threshold that would typically trigger more detailed reporting (Schedule 13D) and suggest potential activist intent, thus it aligns with standard passive investment practices within the asset management industry.

Comparison to Industry Standards

• BlackRock's 4.4% passive stake in Kodiak Sciences Inc. is consistent with typical portfolio allocations for large institutional investors, which often hold minority positions across a broad range of companies without seeking control.
• The filing of a Schedule 13G, rather than a Schedule 13D, indicates that BlackRock's intent is passive, aligning with the standard practice for asset managers primarily focused on investment rather than corporate governance influence.
• The beneficial ownership percentage is below the 5% threshold, which is a common benchmark for triggering more extensive disclosure requirements and often signals a more active investment approach by other funds like activist hedge funds (e.g., Elliott Management, Starboard Value) that typically acquire larger stakes to influence corporate strategy.

Corporate Governance

Stakeholder Impact

• Shareholders of Kodiak Sciences Inc. gain transparency regarding a significant institutional holder, BlackRock, Inc., which may instill confidence due to BlackRock's reputation as a major asset manager.
• The passive nature of the stake indicates that BlackRock is not seeking to influence management or strategic direction, which may reassure current management and board members.

Next Steps

• BlackRock, Inc. will continue to monitor its beneficial ownership in Kodiak Sciences Inc. and file amendments to Schedule 13G as required if its ownership percentage changes significantly (e.g., crosses 5% or drops below 0%).

Key Dates

Keywords

Kodiak Sciences Inc., BlackRock Inc., Schedule 13G, Beneficial Ownership, Common Stock, Passive Investment, Institutional Investor, SEC Filing